Cite
Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice.
MLA
Tanaka, Toshihiro, et al. “Retrospective Analysis of the Efficacy and Safety of Eribulin Therapy for Metastatic Breast Cancer in Daily Practice.” Thoracic Cancer, vol. 8, no. 5, Sept. 2017, pp. 523–29. EBSCOhost, https://doi.org/10.1111/1759-7714.12482.
APA
Tanaka, T., Ueno, M., Nakashima, Y., Chinen, S., Sato, E., Masaki, M., Mogi, A., Sasaki, H., Tamura, K., & Takamatsu, Y. (2017). Retrospective analysis of the efficacy and safety of eribulin therapy for metastatic breast cancer in daily practice. Thoracic Cancer, 8(5), 523–529. https://doi.org/10.1111/1759-7714.12482
Chicago
Tanaka, Toshihiro, Miho Ueno, Yuta Nakashima, Shotaro Chinen, Eiichi Sato, Michio Masaki, Ai Mogi, Hidenori Sasaki, Kazuo Tamura, and Yasushi Takamatsu. 2017. “Retrospective Analysis of the Efficacy and Safety of Eribulin Therapy for Metastatic Breast Cancer in Daily Practice.” Thoracic Cancer 8 (5): 523–29. doi:10.1111/1759-7714.12482.